Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 9

2 Introduction 10

• 2.1 Spinal Cord Stimulators (SCS) Overview 10

3 Products under Development 11

• 3.1 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development 11
• 3.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Territory 12
• 3.3 Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path 13
• 3.4 Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date 14
• 3.5 Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials 15

4 Spinal Cord Stimulators (SCS) - Pipeline Products under Development by Companies 16

• 4.1 Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development 16
• 4.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development 17

5 Spinal Cord Stimulators (SCS) Companies and Product Overview 19

• 5.1 Boston Scientific Corp Company Overview 19
  • 5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 19
• 5.2 Cerevast Therapeutics Inc Company Overview 20
  • 5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.3 Direct Spinal Therapeutics, Inc. Company Overview 21
  • 5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 Duke University Company Overview 22
  • 5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.5 GTX Medical BV Company Overview 23
  • 5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.6 Imperial College London Company Overview 29
  • 5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.7 Lawson Health Research Institute Company Overview 30
  • 5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.8 Meagan Medical Inc. Company Overview 31
  • 5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.9 Medtronic plc Company Overview 34
  • 5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.10 Micro-Leads Inc Company Overview 37
  • 5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.11 MicroTransponder Inc Company Overview 39
  • 5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.12 Neuronoff Inc Company Overview 40
  • 5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.13 Nevro Corp Company Overview 41
  • 5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.14 Nexstim Plc Company Overview 60
  • 5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.15 Nuvectra Corp Company Overview 61
  • 5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview 61
• 5.16 Saluda Medical Pty Ltd Company Overview 62
  • 5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
• 5.17 Soterix Medical Inc Company Overview 65
  • 5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65
• 5.18 SpineX Company Overview 72
  • 5.18.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview 72
• 5.19 St. Jude Medical LLC Company Overview 73
  • 5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73
• 5.20 University of California Los Angeles Company Overview 77
  • 5.20.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 77
• 5.21 University of Minnesota Company Overview 79
  • 5.21.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 79
• 5.22 Wavegate Technologies LLC Company Overview 82
  • 5.22.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82
• 5.23 WISE s.r.l. Company Overview 83
  • 5.23.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 83

6 Spinal Cord Stimulators (SCS)- Recent Developments 84

• 6.1 Nov 25, 2019: Stimwave Technologies halts commercialization of product line in Australia 84
• 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
• 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
• 6.4 Nov 12, 2019: Nuvectra continuing to support current patients with the Algovita Implant as company voluntarily files for chapter 11 88
• 6.5 Nov 08, 2019: University of Wisconsin Madison: Injectable, flexible electrode could replace rigid nerve-stimulating implants 88

7 Appendix 149

• 7.1 Methodology 149
• 7.2 About GlobalData 152
• 7.3 Contact Us 152

Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019" provides an overview of Spinal Cord Stimulators (SCS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators (SCS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Spinal Cord Stimulators (SCS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date